A Phase I/II Study of CP-4055 in Patients with Refractory/Relapsed Hematologic Malignancies

Update Il y a 4 ans
Reference: EUCTR2006-000868-83

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Phase II : Determine the efficacy of single agent CP-4055 in patients receiving second salvage therapy for AML


Inclusion criteria

  • Phase II. Acute Myeloid Leukemia (AML)